PET imaging in gynecologic malignancies
- 30 November 2004
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 42 (6) , 1155-1167
- https://doi.org/10.1016/j.rcl.2004.08.006
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Usefulness of FDG PET for Assessment of Early Recurrent Epithelial Ovarian CancerAmerican Journal of Roentgenology, 2002
- Positron Emission Tomography/Computed Tomography Imaging for the Detection of Recurrent Ovarian and Fallopian Tube Carcinoma: A Retrospective ReviewGynecologic Oncology, 2002
- 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Diagnosis of Recurrent Ovarian CancerGynecologic Oncology, 2001
- A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatmentInternational Journal of Gynecologic Cancer, 2001
- The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancerInternational Journal of Gynecologic Cancer, 1999
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter studyUltrasound in Obstetrics & Gynecology, 1997
- Experience with Positron Emission Tomography (PET) Scans in Patients with Ovarian CancerGynecologic Oncology, 1994
- Whole-Body Positron Emission Tomography with 2-[18F]-Fluoro-2-deoxy-D-glucose Can Detect Recurrent Ovarian CarcinomaGynecologic Oncology, 1993
- Assessment of Primary and Metastatic Ovarian Cancer by Positron Emission Tomography (PET) Using 2-[18F]Deoxyglucose (2-[18F]FDG)Gynecologic Oncology, 1993